Stage IV Melanoma Recruiting Phase 2 Trials for Trametinib (DB08911)

IndicationStatusPhase
DBCOND0028660 (Stage IV Melanoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04059224TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type MelanomaTreatment